BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
date of publication: 2013-02-27
language: English
Cites articles 46
- 2011-11-11
- 2010-09-21
Date
Title
Article - wd:Q36692818